A systematic review and Meta-analysis on the association between Hand-Foot Syndrome (HFS) and Cancer Chemotherapy Efficacy.
- Published in:
- Clinica Terapeutica, 2019, v. 170, n. 5, p. e388, doi. 10.7417/CT.2019.2165
- By:
- Publication type:
- Article
Works matching Hand-foot syndrome (HFS) and cancer
Results: 21
1
2
Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer.
- Published in:
- Gastric Cancer, 2010, v. 13, n. 2, p. 95, doi. 10.1007/s10120-010-0545-4
- By:
- Publication type:
- Article
3
Hand-foot syndrome and survival in patients with advanced non-small-cell lung cancer receiving anlotinib: a subgroup analysis of data from the ALTER 0303 study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 8, p. 1492, doi. 10.1007/s10147-020-01683-0
- By:
- Publication type:
- Article
4
Squamous Cell Cancer of the Skin in a Patient on Maintenance Capecitabine for Metastatic Breast Cancer: A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
5
冷冻疗法对子宫颈癌患者化疗致周围神经病变及 手足综合征的疗效研究.
- Published in:
- Journal of Modern Medicine & Health, 2023, v. 39, n. 2, p. 245, doi. 10.3969/j.issn.1009-5519.2023.02.014
- By:
- Publication type:
- Article
6
Impact of comprehensive nursing on hand-foot syndrome caused by oral capecitabine in breast cancer patients.
- Published in:
- African Journal of Reproductive Health, 2024, v. 28, n. 9, p. 163, doi. 10.29063/ajrh2024/v28i9.15
- By:
- Publication type:
- Article
7
Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 645, doi. 10.1007/s00228-016-2030-4
- By:
- Publication type:
- Article
8
ドセタキセル投与患者における手足症候群の発症と 室内環境との関連性の調査 ：ケースシリーズ.
- Published in:
- Research on Drug Interactions, 2024, v. 48, n. 3, p. 44
- By:
- Publication type:
- Article
9
Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand‐foot syndrome.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 6, p. 957, doi. 10.1002/ijc.34046
- By:
- Publication type:
- Article
10
Pyridoxine for Prevention of Hand-Foot Syndrome Caused by Chemotherapy: A Systematic Review.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072245
- By:
- Publication type:
- Article
11
Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 6, p. 1, doi. 10.1007/s00520-024-08490-7
- By:
- Publication type:
- Article
12
Efficacy of regional cooling + oral dexamethasone for primary prevention of hand-foot syndrome associated with pegylated liposomal doxorubicin.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 5, p. 1, doi. 10.1007/s00520-023-07718-2
- By:
- Publication type:
- Article
13
Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
14
"Navigating through a case of Capecitabine-Induced Hand-Foot Syndrome”.
- Published in:
- Frontiers in Health Informatics, 2024, v. 13, n. 7, p. 806
- By:
- Publication type:
- Article
15
Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 3, p. 435, doi. 10.1007/s00280-020-04128-7
- By:
- Publication type:
- Article
16
Topical henna and curcumin (Alpha®) ointment efficacy for prevention of capecitabine induced hand-foot syndrome: A randomized, triple-blinded, placebo-controlled clinical.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 1, p. 117, doi. 10.1007/s40199-022-00438-8
- By:
- Publication type:
- Article
17
Treatment of capecitabine-induced hand-foot syndrome using a topical retinoid: A case report.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
18
Modeling pegylated liposomal doxorubicin-induced hand-foot syndrome and intestinal mucositis in zebrafish.
- Published in:
- OncoTargets & Therapy, 2014, v. 7, p. 1169, doi. 10.2147/OTT.S63785
- By:
- Publication type:
- Article
19
Prevalence of hand-foot syndrome following chemotherapy for colorectal cancer: a systematic review and meta-analysis.
- Published in:
- International Journal of Colorectal Disease, 2023, v. 38, n. 1, p. 1, doi. 10.1007/s00384-023-04345-5
- By:
- Publication type:
- Article
20
Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221101963
- By:
- Publication type:
- Article
21
Identification of hand-foot syndrome from cancer patients' blog posts: BERT-based deep-learning approach to detect potential adverse drug reaction symptoms.
- Published in:
- PLoS ONE, 2022, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0267901
- By:
- Publication type:
- Article